This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Avian Leukosis Virus Capsid Protein P27 (ALV P27)
Product Overview
BioVenic's Recombinant Avian Leukosis Virus Capsid Protein P27 (ALV P27) is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 25.6 kDa. It can be used for antibody production or for immunoassays.
Specifications
Target Information
Avian leukosis virus (ALV), a member of the Retroviridae family, causes notable economic damage to the global poultry industry through virus-related tumors and decreased productivity in commercial layer and breeder flocks. The P27 protein, a capsid component of ALV, self-assembles into an irregular polyhedron core made up of hexamers and pentamers, encapsulating the genomic RNA-nucleocapsid complex.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in distilled water 1:100 as stock solution. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Zhou, Xiaoyu, et al. "Detection of ALV p27 in cloacal swabs and virus isolation medium by sELISA." BMC veterinary research 15 (2019): 1-7.